溃疡性结肠炎
灌肠
结肠炎
发病机制
药理学
肿瘤坏死因子α
医学
体外
化学
炎症性肠病
免疫学
免疫荧光
脂多糖
细胞因子
炎症
肠神经系统
多发性硬化
内科学
促炎细胞因子
作者
Xue Li,Jianxin Chen,Xuya Zhang,Yushan Gao,Yan Fu,Hong Jiang,Yi Lü
摘要
Activation of enteric glial cells (EGCs) contributes to the pathogenesis of ulcerative colitis (UC). This study examined whether Dibai Enema Liquid (DBE)-an herbal enema combining Sanguisorba officinalis, Bletilla striata, and Acacia catechu-modulates EGC-driven inflammation. LC-MS/MS profiles of DBE constituents and prioritized compounds were docked to S100β. Efficacy was assessed in dextran sulfate sodium (DSS)-induced murine colitis using body weight, colon length, histopathology, and cytokine levels (ELISA). Glial activation markers were measured by immunohistochemistry, immunofluorescence colocalization, quantitative PCR (qPCR), and immunoblotting. An in vitro model used CRL-2690 enteric glia activated with lipopolysaccharide plus interferon-γ, with DBE-containing rat serum (15%) as the intervention. Docking suggested a strong predicted binding of several DBE components to S100β. DSS increased TNF-α and IL-1β, disrupted tight junctions, and elevated S100β/GFAP at both mRNA and protein levels, consistent with glial hyperactivation; DBE significantly reversed these changes. In vitro, DBE reduced S100β, RAGE, iNOS (NOS2), and phosphorylated NF-κB p65. Collectively, DBE appears to alleviate UC by inhibiting EGC activation and downregulating the S100β/RAGE/NF-κB/iNOS axis, thereby preserving mucosal integrity.
科研通智能强力驱动
Strongly Powered by AbleSci AI